<

SANOFI-AVENTIS (EPA:SAN) Nirsevimab significantly protected infants against RSV disease in Phase 3 trial

Transparency directive : regulatory news

03/03/2022 08:00



Other stories

19/04/2024 12:41
19/04/2024 06:02
19/04/2024 12:09
19/04/2024 00:07
19/04/2024 12:00
19/04/2024 09:28
19/04/2024 07:54
18/04/2024 23:40
19/04/2024 07:13
19/04/2024 11:57
19/04/2024 01:40
19/04/2024 10:15
18/04/2024 16:01
18/04/2024 16:35
19/04/2024 09:37
19/04/2024 01:11
19/04/2024 10:03
19/04/2024 07:27
18/04/2024 19:44
18/04/2024 14:11
17/04/2024 22:35
17/04/2024 13:30
19/04/2024 12:48
19/04/2024 08:00
18/04/2024 21:09
19/04/2024 08:31
19/04/2024 10:30
19/04/2024 12:04
19/04/2024 00:03
19/04/2024 11:21
18/04/2024 11:33
19/04/2024 12:59
17/04/2024 13:42
18/04/2024 17:58
18/04/2024 21:46
18/04/2024 08:00
18/04/2024 22:18
19/04/2024 12:09